The Journal of Pathology · 2007 · 96 citations · 25 references
Veterinary MedicineInfectious DiseasesMolecular BiologyNeurodegenerationNeurogeneticsPrion DiseasesCreutzfeldt-jakob DiseaseNeurodegenerative DisordersPrion Disease DiagnosisPrion Protein MisfoldingPrion ReplicationAmplificationPrion Amplification AssaysPrion PathogenesisPrion Protein FoldingProtease-resistant Prion ProteinProteinase K ResistanceTransgenic Mouse ModelsVariant Creutzfeldt-jakob Disease Diagnosis
Variant Creutzfeldt-Jakob disease (vCJD) poses a serious risk of secondary transmission and the need to detect infectivity in asymptomatic individuals is therefore of major importance. Following infection, it is assumed that minute amounts of disease-associated prion protein (PrP(Sc)) replicate by conversion of the host cellular prion protein (PrP(C)). Therefore, methods of rapidly reproducing this conversion process in vitro would be valuable tools in the development of such tests. We show that one such technique, protein misfolding cyclic amplification (PMCA), can amplify vCJD PrP(Sc) from human brain tissue, and that the degree of amplification is dependent upon the substrate PRNP codon 129 polymorphism. Both human platelets and transgenic mouse brain are shown to be suitable alternative substrate sources, and amplified PrP(Sc) can be detected using a conformation-dependent immunoassay (CDI), allowing the detection of putative proteinase K sensitive forms of PrP(Sc).
25
A new variant of Creutzfeldt-Jakob disease in the UK
Robert Will, James W. Ironside, Martin Zeidler et al. · The Lancet · 1996 · 2.7K citations
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
M. E. Bruce, Robert Will, James W. Ironside et al. · Nature · 1997 · 2K citations
Eight prion strains have PrPSc molecules with different conformations
Jiri Safar, Holger Wille, Vincenza Itri et al. · Nature Medicine · 1998 · 1.2K citations